Structure-based functional design of drugs: from target to lead compound.
Structure-based functional design of drugs: from target to lead compound.
复制标题
DOI：
10.1007/978-1-60327-216-2_23
复制
发表时间：
2012
期刊：
影响因子：
--
通讯作者：
Anderson, Amy C
中科院分区：
文献类型：
--
作者：
Anderson, Amy C
Proteomic and genomic discoveries have identified vast numbers of new drug targets for investigation. In the quest to discover drugs that modulate the function of these targets, identification of small-molecule drug leads is one of the earliest steps. Structure-based drug design has emerged as a valuable, inexpensive, and rapid computational resource that identifies lead compounds that are complementary to the structure of the target. Leads identified through this process are biologically evaluated and “hit compounds” with affinity and activity are further optimized. This chapter introduces the process of structure-based drug design, including preparation of the ligand database, preparation of the target structure, docking and scoring, and evaluation.
